The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study
Abstract
RATIONALE: Chronic obstructive pulmonary disease (COPD) is characterized by an accelerated decline in lung function. No drug has been shown conclusively to reduce this decline. OBJECTIVES: In a post hoc analysis of the Toward a Revolution in COPD Health (TORCH) study, we investigated the effects of combined salmeterol 50 microg plus fluticasone propionate 500 microg, either component alone or placebo, on the rate of post-bronchodilator FEV(1) decline in patients with moderate or severe COPD. METHODS: A randomized, double-blind, placebo-controlled study was conducted from September 2000 to November 2005 in 42 countries. Of 6,112 patients from the efficacy population, 5,343 were included in this analysis. MEASUREMENTS AND MAIN RESULTS: Spirometry was measured every 24 weeks for 3 years. There were 26,539 on-treatment observations. The adjusted rate of decline in FEV(1) was 55 ml/year for placebo, 42 ml/year for salmeterol, 42 ml/year for fluticasone propionate, and 39 ml/year for salmeterol plus fluticasone propionate. Salmeterol plus fluticasone propionate reduced the rate of FEV(1) decline by 16 ml/year compared with placebo (95% confidence interval [CI], 7-25; P < 0.001). The difference was smaller for fluticasone propionate and salmeterol compared with placebo (13 ml/year; 95% CI, 5-22; P = 0.003). Rates of decline were similar among the active treatment arms. FEV(1) declined faster in current smokers and patients with a lower body mass index, and varied between world regions. Patients who exacerbated more frequently had a faster FEV(1) decline. CONCLUSIONS: Pharmacotherapy with salmeterol plus fluticasone propionate, or the components, reduces the rate of decline of FEV(1) in patients with moderate-to-severe COPD, thus slowing disease progression. Clinical trial (GSK Study Code SCO30003) registered with www.clinicaltrials.gov (NCT00268216).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Standardization of Spirometry, 1994 Update. American Thoracic Society.
(1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.3.7663792 · Cited by 6,594
Global Initiative for Chronic Obstructive Lung Disease
Gerald, L. B., & Bailey, W. C. (2002) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200207000-00004 · Cited by 5,830
Lung volumes and forced ventilatory flows
Quanjer, P. H., Tammeling, G. J., Cotes, J. E., Pedersen, O. F., Peslin, R., & Yernault, J.-C. (1993) · European Respiratory Journal · doi:10.1183/09041950.005s1693 · Cited by 5,318
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Self-citationCelli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015
Self-citation(1993) · PubMed · Cited by 3,827
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
Hogg, J. C., Chu, F., Utokaparch, S., Woods, R., Elliott, W. M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032158 · Cited by 3,782
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., & Vestbo, J. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa063070 · Cited by 3,248
Self-citationThe natural history of chronic airflow obstruction.
Fletcher, C., & Peto, R. (1977) · BMJ · doi:10.1136/bmj.1.6077.1645 · Cited by 2,370
Donaldson, G. C. (2002) · Thorax · doi:10.1136/thorax.57.10.847 · Cited by 2,272
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
A 15-year follow-up study of ventilatory function in adults with asthma
Lange, P., Parner, J., Vestbo, J., Schnohr, P., & Jensen, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391703 · Cited by 1,250 · cited 1×
“The normal rate of FEV1 decline in healthy subjects is approximately 30 ml/year (24, 25 ).”
BackgroundSelf-citationCalverley, P., Pauwels, R., Vestbo, J., Jones, P., Pride, N., Gulsvik, A., Anderson, J., & Maden, C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12459-2 · Cited by 1,221
Self-citationWeight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Pauwels, R. A., Löfdahl, C.-G., Laitinen, L. A., Schouten, J. P., Postma, D. S., Pride, N. B., & Ohlsson, S. V. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402503 · Cited by 1,074
Szafranski, W., Cukier, A., Ramirez, A., Menga, G., Sansores, R., Nahabedian, S., Peterson, S., & Olsson, H. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00031402 · Cited by 887
(2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432601 · Cited by 830
Vestbo, J., Søorensen, T., Lange, P., Brix, A., Torre, P., & Viskum, K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10019-3 · Cited by 816
Self-citationSCANLON, P. D., CONNETT, J. E., WALLER, L. A., ALTOSE, M. D., BAILEY, W. C., SONIA BUIST, A., & e Lung Health Study Research Group, D. P. T. F. T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9901044 · Cited by 731
Epidemiology and costs of chronic obstructive pulmonary disease
Chapman, K. R., Mannino, D. M., Soriano, J. B., Vermeire, P. A., Buist, A. S., Thun, M. J., Connell, C., Jemal, A., Lee, T. A., Miravitlles, M., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024505 · Cited by 704
Smoking and Lung Function of Lung Health Study Participants after 11 Years
Anthonisen, N. R., Connett, J. E., & Murray, R. P. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112096 · Cited by 697
Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P. R., Troosters, T., van Herwaarden, C., Pellegrino, R., van Schayck, C. O., Olivieri, D., Del Donno, M., De Backer, W., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66456-2 · Cited by 684
KANNER, R. E., ANTHONISEN, N. R., & CONNETT, J. E. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.3.2010017 · Cited by 583
Buist, A. S., & Connett, J. E. (1993) · Chest · doi:10.1378/chest.103.6.1644a · Cited by 483
Decline in Lung Function in the Busselton Health Study
James, A. L., Palmer, L. J., Kicic, E., Maxwell, P. S., Lagan, S. E., Ryan, G. F., & Musk, A. W. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-230oc · Cited by 397
Antiinflammatory Effects of Salmeterol/Fluticasone Propionate in Chronic Obstructive Lung Disease
Barnes, N. C., Qiu, Y.-S., Pavord, I. D., Parker, D., Davis, P. A., Zhu, J., Johnson, M., Thomson, N. C., & Jeffery, P. K. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1321oc · Cited by 253
The TORCH (TOwards a Revolution in COPD Health) survival study protocol: Fig. 1.—
The TORCH Study Group (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00120603 · Cited by 224
Sutherland, E. R. (2003) · Thorax · doi:10.1136/thorax.58.11.937 · Cited by 220
Pauwels, R., Lofdahl, C., Pride, N., Postma, D., Laitinen, L., & Ohlsson, S. (1992) · European Respiratory Journal · doi:10.1183/09031936.93.05101254 · Cited by 217
Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD
Powrie, D. J., Wilkinson, T. M. A., Donaldson, G. C., Jones, P., Scrine, K., Viel, K., Kesten, S., & Wedzicha, J. A. (2007) · European Respiratory Journal · doi:10.1183/09031936.00023907 · Cited by 178
Self-citationDecramer, M., Celli, B., Tashkin, D. P., Pauwels, R. A., Burkhart, D., Cassino, C., & Kesten, S. (2004) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200026934 · Cited by 169
Self-citationMethodological issues in therapeutic trials of COPD
Suissa, S., Ernst, P., Vandemheen, K. L., & Aaron, S. D. (2008) · European Respiratory Journal · doi:10.1183/09031936.00098307 · Cited by 160
Alternative Mechanisms for Long-Acting β2-Adrenergic Agonists in COPD
Johnson, M., & Rennard, S. I. (2001) · CHEST Journal · doi:10.1378/chest.120.1.258 · Cited by 156
A Pooled Analysis of FEV 1 Decline in COPD Patients Randomized to Inhaled Corticosteroids or Placebo
Soriano, J. B., Sin, D. D., Zhang, X., Camp, P. G., Anderson, J. A., Anthonisen, N. R., Buist, A. S., Burge, P. S., Calverley, P. M. A., Connett, J. E., et al. (2007) · CHEST Journal · doi:10.1378/chest.06-1696 · Cited by 128
Self-citationWithdrawal From Treatment as an Outcome in the ISOLDE Study of COPD
Calverley, P. M. A., Spencer, S., Willits, L. R., Burge, P. S., & Jones, P. (2003) · CHEST Journal · doi:10.1378/chest.124.4.1350 · Cited by 121
Self-citationAddition of salmeterol to existing treatment in patients with COPD: a 12 month study
STOCKLEY, R. A., Chopra, N., & Rice, L. (2006) · Thorax · doi:10.1136/thx.2004.033266 · Cited by 97
Gene Silencing in Severe Systemic Inflammation
McCall, C. E., & Yoza, B. K. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200610-1436cp · Cited by 89
Stockley, R. A., Whitehead, P. J., & Williams, M. K. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-147 · Cited by 52
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Self-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Self-citationLung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Lange, P., Celli, B., Agustí, A., Boje Jensen, G., Divo, M., Faner, R., Guerra, S., Marott, J. L., Martinez, F. D., Martinez-Camblor, P., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411532 · Cited by 1,284
Self-citationQaseem, A., Wilt, T. J., Weinberger, S. E., Hanania, N. A., Criner, G., van der Molen, T., Marciniuk, D. D., Denberg, T., Schünemann, H., Wedzicha, W., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-3-201108020-00008 · Cited by 1,087
Chronic obstructive pulmonary disease
Decramer, M., Janssens, W., & Miravitlles, M. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60968-9 · Cited by 972
Metadata
- Authors
- Celli, B. R., Thomas, N. E., Anderson, J. A., Ferguson, G. T., Jenkins, C. R., Jones, P. W., Vestbo, J., Knobil, K., Yates, J. C., & Calverley, P. M. A.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-08-15
- Volume
- 178
- Issue
- 4
- Pages
- 332-338
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1920721512
- Cited by
- 748
- References
- 39
- FWCI
- 65.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.